Sands Capital Management — REGN Trade History
Quarter-by-quarter changes in the REGENERON PHARMACEUTICALS position · CUSIP 75886F107
Sold outFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | — | — | — | — | — | — |
| 2026 Q1 | 2026-05-08 | — | — | — | — | — | — |
| 2025 Q4 | 2026-02-13 | — | — | — | — | — | — |
| 2025 Q3 | 2025-11-13 | — | — | — | — | — | — |
| 2025 Q2 | 2025-08-13 | — | — | — | — | — | — |
| 2025 Q1 | 2025-05-14 | — | — | — | — | — | — |
| 2024 Q4 | 2025-02-13 | — | — | — | — | — | — |
| 2024 Q3 | 2024-11-13 | — | — | — | — | — | — |
| 2024 Q2 | 2024-08-13 | — | — | — | — | — | — |
| 2024 Q1 | 2024-05-14 | — | — | — | — | — | — |
| 2023 Q4 | 2024-02-13 | — | — | — | — | — | — |
| 2023 Q3 | 2023-11-14 | — | — | — | — | — | — |
| 2023 Q2 | 2023-08-15 | — | — | — | — | — | — |
| 2023 Q1 | 2023-05-12 | — | — | — | — | — | — |
| 2022 Q4 | 2023-02-13 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-09 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-12 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-13 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-11 | — | — | — | — | — | — |
| 2021 Q3 | 2021-11-03 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-16 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-17 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-17 | Sold out | — | -856,472 | -100.0% | — | — |
| 2020 Q3 | 2020-11-17 | Add | 856,472 | 17,057 | +2.0% | $479.4M | 1.04% |
| 2020 Q2 | 2020-08-11 | Add | 839,415 | 695 | +0.1% | $523.5M | 1.27% |
| 2020 Q1 | 2020-05-14 | Reduce | 838,720 | -13,991 | -1.6% | $409.5M | 1.37% |
| 2019 Q4 | 2020-02-13 | Reduce | 852,711 | -36,777 | -4.1% | $320.2M | 0.93% |
| 2019 Q3 | 2019-11-14 | Reduce | 889,488 | -81,678 | -8.4% | $246.7M | 0.79% |
| 2019 Q2 | 2019-08-14 | Reduce | 971,166 | -1,016,547 | -51.1% | $304.0M | 0.90% |
| 2019 Q1 | 2019-05-15 | Reduce | 1,987,713 | -93,116 | -4.5% | $816.2M | 2.52% |
| 2018 Q4 | 2019-02-14 | Reduce | 2,080,829 | -96,564 | -4.4% | $777.2M | 2.77% |
| 2018 Q3 | 2018-11-14 | Reduce | 2,177,393 | -128,418 | -5.6% | $879.8M | 2.49% |
| 2018 Q2 | 2018-08-14 | Reduce | 2,305,811 | -98,276 | -4.1% | $795.5M | 2.28% |
| 2018 Q1 | 2018-05-15 | Reduce | 2,404,087 | -152,525 | -6.0% | $827.9M | 2.45% |
| 2017 Q4 | 2018-02-14 | New | 2,556,612 | 2,556,612 | — | $961.2M | 2.91% |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-12 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-13 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.